Endothelial cell regulators

Endothelial cell regulators represent a broad functional category of molecules rather than a single therapeutic target. This group encompasses a diverse array of proteins, including growth factors like Vascular Endothelial Growth Factor (VEGF) and Angiopoietins, receptors such as Tie-2 and VEGFRs, and homeostatic mediators like thrombomodulin and nitric oxide synthase. These regulators are essential for maintaining vascular integrity, controlling angiogenesis and lymphangiogenesis, and managing hemostasis. In pathological states, dysregulation of these factors contributes significantly to tumor neovascularization, chronic inflammation, and cardiovascular diseases. Therapeutic strategies often involve targeting specific members of this class, such as using monoclonal antibodies to neutralize VEGF or small-molecule inhibitors to block tyrosine kinase signaling, thereby inhibiting disease progression and normalizing vascular function.

Other names

Vascular regulatorsAngiogenic factorsEndothelial mediatorsHemostatic regulators

Inhibition of vascular endothelial growth factor (VEGF) signaling, multi-targeted tyrosine kinase inhibition (VEGFR, PDGFR, KIT), complement system inhibition (C5), and PI3K-gamma inhibition to modulate myeloid cell trafficking and vascular leak.